101,100 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Purchased by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 101,100 shares of the company's stock, valued at approximately $2,346,000. Tudor Investment Corp ET AL owned approximately 0.06% of Option Care Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also added to or reduced their stakes in the company. Wellington Management Group LLP lifted its position in shares of Option Care Health by 84.6% in the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after buying an additional 8,400,208 shares in the last quarter. Norges Bank bought a new stake in shares of Option Care Health in the 4th quarter worth about $60,219,000. Dimensional Fund Advisors LP raised its position in shares of Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after buying an additional 591,042 shares in the last quarter. Victory Capital Management Inc. grew its position in Option Care Health by 31.1% in the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock worth $49,310,000 after acquiring an additional 503,840 shares in the last quarter. Finally, Magnetar Financial LLC increased its stake in Option Care Health by 23.1% during the fourth quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock worth $54,534,000 after acquiring an additional 441,265 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Analysts Set New Price Targets

OPCH has been the subject of a number of analyst reports. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Wednesday, April 30th. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. raised their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Finally, Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Stock Up 1.0 %

Shares of OPCH traded up $0.31 during mid-day trading on Friday, hitting $32.01. The company's stock had a trading volume of 576,708 shares, compared to its average volume of 1,834,356. The firm has a market capitalization of $5.24 billion, a price-to-earnings ratio of 26.90, a PEG ratio of 2.30 and a beta of 0.76. The company's 50-day moving average is $33.29 and its 200-day moving average is $28.89. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm's quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.26 EPS. On average, equities research analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.64% of the stock is owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.